Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Olszanski AJ"'
Autor:
Lewis NL, Lewis LD, Eder JP, Reddy NJ, Guo F, Pierce KJ, Olszanski AJ, Cohen RB, Lewis, Nancy L, Lewis, Lionel D, Eder, Joseph P, Reddy, Nandi J, Guo, Feng, Pierce, Kristen J, Olszanski, Anthony J, Cohen, Roger B
Publikováno v:
Journal of Clinical Oncology; 11/1/2009, Vol. 27 Issue 31, p5262-5269, 8p
Autor:
Schiller JH, Larson T, Ou SH, Limentani S, Sandler A, Vokes E, Kim S, Liau K, Bycott P, Olszanski AJ, von Pawel J
Publikováno v:
Journal of Clinical Oncology; 8/10/2009, Vol. 27 Issue 23, p3836-3841, 6p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Swetter SM; Stanford Cancer Institute., Johnson D; Vanderbilt-Ingram Cancer Center., Albertini MR; University of Wisconsin Carbone Cancer Center., Barker CA; Memorial Sloan Kettering Cancer Center., Bateni S; O'Neal Comprehensive Cancer Center at UAB., Baumgartner J; UC San Diego Moores Cancer Center., Bhatia S; Fred Hutchinson Cancer Center., Bichakjian C; University of Michigan Rogel Cancer Center., Boland G; Mass General Cancer Center., Chandra S; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Chmielowski B; UCLA Jonsson Comprehensive Cancer Center., DiMaio D; Fred & Pamela Buffett Cancer Center., Dronca R; Mayo Clinic Comprehensive Cancer Center., Fields RC; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Fleming MD; The University of Tennessee Health Science Center., Galan A; Yale Cancer Center/Smilow Cancer Hospital., Guild S; AIM at Melanoma., Hyngstrom J; Huntsman Cancer Institute at the University of Utah., Karakousis G; Abramson Cancer Center at the University of Pennsylvania., Kendra K; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Kiuru M; UC Davis Comprehensive Cancer Center., Lange JR; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Lanning R; University of Colorado Cancer Center., Logan T; Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Olson D; The UChicago Medicine Comprehensive Cancer Center., Olszanski AJ; Fox Chase Cancer Center., Ott PA; Dana-Farber/Brigham and Women's Cancer Center., Ross MI; The University of Texas MD Anderson Cancer Center., Rothermel L; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Salama AK; Duke Cancer Institute., Sharma R; UT Southwestern Simmons Comprehensive Cancer Center., Skitzki J; Roswell Park Comprehensive Cancer Center., Smith E; University of Michigan Rogel Cancer Center., Tsai K; UCSF Helen Diller Family Comprehensive Cancer Center., Wuthrick E; Moffitt Cancer Center., Xing Y; City of Hope National Medical Center., McMillian N; National Comprehensive Cancer Network., Espinosa S; National Comprehensive Cancer Network.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Jul; Vol. 22 (5), pp. 290-298.
Autor:
Juric D; Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Barve M; Medical Oncology, Mary Crowley Cancer Research, Dallas, Texas, USA., Vaishampayan U; Internal Medicine/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA., Roda D; Department of Medical Oncology, University Hospital, Valencia, Spain., Calvo A; Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Jañez NM; Department of Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Trigo J; Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Greystoke A; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Harvey RD; Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Olszanski AJ; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA., Opyrchal M; Division of Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri, USA., Spira A; Medical Oncology, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.; Medical Oncology, Virginia Cancer Specialists, US Oncology Research, NEXT Oncology Virginia, Leesburg, Virginia, USA., Thistlethwaite F; Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Jiménez B; Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain., Sappal JH; Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Kannan K; Oncology Therapeutic Area Unit, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Riley J; Gastroenterology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Li C; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Li C; Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Gregory RC; Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Miao H; Clinical Development, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA., Wang S; Takeda Oncology Clinical Science, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5).
Autor:
Restifo D; The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., McDermott JR; Lantern Pharma Inc., Dallas, Texas., Cvetkovic D; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Dos Santos T; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Ogier C; The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Surumbayeva A; The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Handorf EA; Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Schimke C; Lantern Pharma Inc., Dallas, Texas., Ma C; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Cai KQ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Olszanski AJ; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Kathad U; Lantern Pharma Inc., Dallas, Texas., Bhatia K; Lantern Pharma Inc., Dallas, Texas., Sharma P; Lantern Pharma Inc., Dallas, Texas., Kulkarni A; Lantern Pharma Inc., Dallas, Texas., Astsaturov I; The Marvin & Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2023 Oct 02; Vol. 22 (10), pp. 1182-1190.
Autor:
Rasco DW; South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX, USA., Medina T; University of Colorado Cancer Center, Aurora, CO, USA., Corrie P; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Pavlick AC; Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York, NY, USA., Middleton MR; Department of Oncology, NIHR Biomedical Research Centre, Oxford, UK., Lorigan P; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, UK., Hebert C; Bristol Haematology and Oncology Centre, Bristol, UK., Plummer R; The Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK., Larkin J; The Royal Marsden Hospital, London, UK., Agarwala SS; St. Luke's Cancer Center and Temple University, Easton, PA, USA., Daud AI; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Qiu J; Day One Biopharmaceuticals, 2000 Sierra Point Parkway, Suite 501, Brisbane, CA, 94005, USA., Bozon V; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Kneissl M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Barry E; Day One Biopharmaceuticals, 2000 Sierra Point Parkway, Suite 501, Brisbane, CA, 94005, USA. elly.barry@dayonebio.com., Olszanski AJ; Fox Chase Cancer Center, Philadelphia, PA, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2023 Jul; Vol. 92 (1), pp. 15-28. Date of Electronic Publication: 2023 May 23.
Autor:
Kottschade LA; Mayo Clinic, Rochester, Minnesota., Pond GR; Ontario Clinical Oncology Group, McMaster University, Hamilton, Ontario., Olszanski AJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Zakharia Y; University of Iowa, Iowa City, Iowa., Domingo-Musibay E; University of Minnesota, Minneapolis, Minnesota., Hauke RJ; Nebraska Cancer Specialists-Midwest Cancer Center, Omaha, Nebraska., Curti BD; Portland Providence Medical Center, Portland, Oregon., Schober S; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Milhem MM; University of Iowa, Iowa City, Iowa., Block MS; Mayo Clinic, Rochester, Minnesota., Hieken T; Mayo Clinic, Rochester, Minnesota., McWilliams RR; Mayo Clinic, Rochester, Minnesota.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 13; Vol. 29 (12), pp. 2220-2225.
Autor:
Shoushtari AN; Department of Medicine (Melanoma Service), Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York., Olszanski AJ; Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway., Hornyak TJ; Department of Dermatology and University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Wolchok JD; Department of Medicine (Melanoma Service), Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medicine, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Levitsky V; Research and Development, Targovax ASA, Oslo, Norway., Kuryk L; Research and Development, Targovax ASA, Oslo, Norway., Hansen TB; Research and Development, Targovax ASA, Oslo, Norway., Jäderberg M; Research and Development, Targovax ASA, Oslo, Norway.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 04; Vol. 29 (1), pp. 100-109.